We are live on ! Find out more
LAB icon

Standard BioTools
LAB

107 hedge funds and large institutions have $1.15B invested in Standard BioTools in 2014 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 47 increasing their positions, 34 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

164% more call options, than puts

Call options by funds: $37.7M | Put options by funds: $14.3M

69% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 13

38% more repeat investments, than reductions

Existing positions increased: 47 | Existing positions reduced: 34

23% more capital invested

Capital invested by funds: $941M → $1.15B (+$213M)

7% more funds holding

Funds holding: 100 → 107 (+7)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

Holders
107
Holders Change
+7
Holders Change %
+7%
% of All Funds
3.09%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
22
Increased
47
Reduced
34
Closed
13
Calls
$37.7M
Puts
$14.3M
Net Calls
+$23.4M
Net Calls Change
+$20.9M

Top Buyers

1
Franklin Resources
Franklin Resources
California
+$47.5M
2
ZCI
Zevenbergen Capital Investments
Washington
+$19.7M
3
O
OppenheimerFunds
New York
+$17.4M
4
Jennison Associates
Jennison Associates
New York
+$14.4M
5
VAM
Visium Asset Management
New York
+$9.62M

Top Sellers

1
Fidelity Investments
Fidelity Investments
Massachusetts
-$17.6M
2
Lord, Abbett & Co
Lord, Abbett & Co
New Jersey
-$15.8M
3
CAM
Cortina Asset Management
Wisconsin
-$12.9M
4
FA
Friess Associates
Delaware
-$9.68M
5
JP Morgan Chase
JP Morgan Chase
New York
-$6.47M
Name Holding Trade Value Shares
Change 		Change in
Stake
Allianz Asset Management
26
Allianz Asset Management
Germany
$8.32M +$8.38M +190,445 New
DCM
27
Driehaus Capital Management
Illinois
$8.1M +$4.25M +96,556 +111%
Bank of New York Mellon
28
Bank of New York Mellon
New York
$6.74M -$923K -20,976 -12%
Geode Capital Management
29
Geode Capital Management
Massachusetts
$6.72M +$1.07M +24,374 +19%
CCS
30
Crosspoint Capital Strategies
California
$5.73M +$46K +1,046 +0.8%
BLM
31
Bennett Lawrence Management
New York
$5.08M +$5.07M +115,290 New
RFC
32
Russell Frank Company
Washington
$4.9M +$343K +7,795 +6%
TCIM
33
TIAA CREF Investment Management
New York
$4.64M -$122K -2,780 -3%
OM
34
Opaleye Management
Massachusetts
$3.97M -$1.87M -42,500 -32%
D.E. Shaw & Co
35
D.E. Shaw & Co
New York
$3.81M +$246K +5,596 +7%
Principal Financial Group
36
Principal Financial Group
Iowa
$3.47M -$470K -10,676 -12%
WSA
37
Wall Street Associates
California
$3.37M -$48.4K -1,100 -1%
Stifel Financial
38
Stifel Financial
Missouri
$3.22M +$3.22M +73,149 New
Charles Schwab
39
Charles Schwab
California
$3.21M +$84.3K +1,917 +3%
BIM
40
BlackRock Investment Management
Delaware
$3.09M +$7.17K +163 +0.2%
FLAM
41
First Light Asset Management
Minnesota
$3.02M +$451K +10,240 +18%
Deutsche Bank
42
Deutsche Bank
Germany
$2.65M +$835K +18,980 +46%
CS
43
Credit Suisse
Switzerland
$2.43M +$267K +6,068 +12%
1832 Asset Management
44
1832 Asset Management
Ontario, Canada
$2.4M -$128K -2,900 -5%
ICM
45
IronBridge Capital Management
Illinois
$2.38M +$2.38M +54,040 New
PAM
46
Panagora Asset Management
Massachusetts
$2.35M +$65.3K +1,485 +3%
Ohio Public Employees Retirement System (OPERS)
47
Ohio Public Employees Retirement System (OPERS)
Ohio
$2.34M -$152K -3,463 -6%
NFA
48
Nationwide Fund Advisors
Ohio
$2.18M +$801K +18,208 +58%
KIA
49
Kopp Investment Advisors
Minnesota
$2.16M +$2.16M +49,048 New
Goldman Sachs
50
Goldman Sachs
New York
$2.16M +$78.9K +1,793 +4%
1
2
3 4 5

LAB Hedge Fund Activity: Q1 2014 in Review

107 of the 3,462 institutional investors tracked by Wall St. Rank reported a position in Standard BioTools (LAB) for Q1 2014, worth a combined $1.15B — up 23% from $941M a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new LAB positions and 13 closed out — a net gain of 9 holders — while 47 added to existing stakes and 34 trimmed.

The largest buyer was Franklin Resources, opening a new position worth an estimated $47.5M. The largest seller was Fidelity Investments, cutting an estimated $17.6M.

  • 107 institutional investors held Standard BioTools (LAB) as of Q1 2014, up from 100 in Q4 2013.
  • Funds reported $1.15B of Standard BioTools stock for Q1 2014, up 23% quarter-over-quarter.
  • 22 funds opened new Standard BioTools positions in Q1 2014 and 13 closed out, a net change of +9 holders.
  • The largest Standard BioTools buyer in Q1 2014 was Franklin Resources, an estimated $47.5M added.
  • The largest Standard BioTools seller in Q1 2014 was Fidelity Investments, an estimated $17.6M sold.

Based on aggregated 13F filings for Q1 2014.